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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S424trials was modest (mean Jadad score ¼ 2.08). All studies reported a
positive association between 2 to 5 weeks of Herbal Medicated-Bath
Therapy and improved clinical pain symptoms compared with non-
steroidal anti-inﬂammatory analgesics or hyaluronate injection con-
trols. Mild adverse events were reported in both groups. Discordant trial
designs, lack of reported sufﬁcient qualitative outcome measures and
other methodological limitations precluded a pooled meta-analysis.
Conclusions: These studies suggest that Chinese Herbal Medicated
Bath Therapy may be helpful in the treatment of pain symptoms in
patients with KOA; however, most studies aremodest in quality. Further
rigorously designed and well-controlled RCTs are warranted.Table 1
Lipidomic proﬁles of OA articular cartilage in response to mTOR regulation
m/z peak Lipid assignment Designation Condition
104 Choline [M+H]+ Rapamycin
184 Phosphocholine [M+H]+ Rapamycin
2 Palmitoleamide [M+H]+ Control
285 Stearic acid [M+H]+ Rapamycin
304,2 Arachidonic acid [M+H]+ Control
522,6 Phosphocholine (18:1) [M+H]+ Rapamycin
582,3 Rapamycin Rapamycin
666,4 From m/z Sphingomyelin [M+Na]+ Rapamycin
725,4 Sphingomyelin [M+Na]+ Rapamycin
936,5 Rapamycin [M+Na]+ RapamycinProteomics & Metabolomics
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Purpose: There is increasing evidence indicating that lipid accumu-
lation increases with aging and OA, perhaps contributing to the chon-
drocyte dysfunction. The mammalian target of rapamycin (mTOR) is a
conserved serine-threonine kinase that regulates cell growth, cellular
proliferation and metabolism in response to nutrient signals. In fact, it
has been demonstrated that mTOR mediates in the onset and pro-
gression of diabetes, cancer and ageing process. However, the speciﬁc
involvement of mTOR in the regulation of lipid metabolism in articular
cartilage is poorly understood. The objective of this study is to deter-
mine the effect of mTOR inhibition in the regulation of the lipid
metabolism in human articular cartilage.
Methods: OA cartilage slices were treated with mTORC1 selective
inhibitor Rapamycin (Rapa, 10 mM), mTORC1 and mTORC2 inhibitor
Torin 1 (75 nM), as well as with a limited medium under tissue star-
vation conditions (Hank’s Balance Salt solution, HBSS) for 24 hours. Oil
Red and Nile blue stainings were performed to analyze the effect of
mTOR inhibitors on lipidic species present in OA articular cartilage.
Matrix Assisted Laser Desorption Ionization Mass Spectrometry Imag-
ing (MALDI-MSI) was used to study the differential lipidomic proﬁles
under all conditions. Samples were sectioned in triplicate in 10 mm thick
sections. 2,5-dihydroxybenzoic acid (DHB) matrix at 20 mg/mL in 20
mg/mL MeOH:AcN (50:50) was deposited by a vibrational sprayer
system. A Synapt HDMS MALDI-Q-TOF instrument was used to perform
the imaging-MS and MS/MS experiments with a spatial raster size of
150 mm. Principal Component Analysis (PCA) and Discriminant Analysis
(DA) were used to build regional molecular classiﬁers. Biomap software
was used to visualize molecular distributions. The Lipid Maps database
was used for lipid identiﬁcation.
Results: Lipid histological staining demonstrate that the inhibition of
mTOR dramatically decreases the lipid pool positive staining in OA
articular cartilage, indicating a direct regulation of lipid dynamics by
both pharmacological and physiological regulation of mTOR. However,
the histological analysis was insufﬁcient to detect and identify speciﬁc
lipid species. We employed a MALDI-MSI analysis to extend our
understanding of these processes. PCA and DA revealed different lip-
idomic proﬁles among control, rapamycin, torin and starvation con-
ditions. Firstly, we analyzed the four conditions in a single dataset
where the ﬁrst discriminant function (DF1) clearly separated the
nutrient depleted tissue from the other groups. DF2 predominantly
distinguished between control and rapamycin treated tissue. DA
revealed that Palmitoleamide and Arachidonic acid were increased in
the control condition whereas Phosphocholine and Sphingomyelin
related peaks were speciﬁc from rapamycin condition (Table 1). In
addition, rapamycin fragments were found in the treated samples of
this drug such as m/z 582.3 and m/z 936.5 demonstrating the capability
of the technique to study the lipid metabolism in addition to drug
metabolism in the cartilage.Conclusions: The MSI analysis data indicates that the mTOR regulates
the lipid proﬁle of human OA cartilage. The palmitoleamide and
arachidonic acid, the lipid species identiﬁed on control condition had
been implicated in the aging process and in the regulation of inﬂam-
matory mediators, such as leukotrienes and prostaglandins, respec-
tively. Interestingly, rapamycin treatment modiﬁed the lipid proﬁle to
choline, phosphocholine or sphingomyelin, all implicated to maintain
the cellular membrane integrity. In summary, these results demonstrate
that MALDI-MSI analysis is a useful tool in the study of lipid and ele-
mental composition changes associated with rheumatic pathologies
and exhibit outstanding diagnostic potential.765
QUANTITATIVE PROTEOMIC ANALYSIS REVEALED DIFFERENTIALLY
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Purpose: Chondrogenesis occurs as a result of mesenchymal stem cells
(MSCs) condensation and chondroprogenitor cell differentiation. Fol-
lowing chondrogenesis, the chondrocytes remain as resting cells to
form the articular cartilage. A major challenge for the osteoarthitic (OA)
cartilage reparation by stem cell-based approaches is the under-
standing of this multi-step process. In this work, we have analyzed the
extracellular protein expression proﬁle of human bone marrow MSCs
(hBMSCs) of osteoarthritic patients and control donors undergoing
chondrogenesis, in order to compare the mechanisms involved in the
cartilage extracellular matrix (ECM) remodeling that occurs during the
chondrogenic differentiation process.
Methods: hBMSCs isolated from 3 OA patients and 3 healthy controls
were grownwith different isotope variants of lysine and arginine (Arg6,
Lys4 for the control population and Arg10, Lys8 for the OA population)
during 4-6 weeks, until achievement of full protein labeling. The labeled
populations were then subjected to differentiation in 3D cultures
(micromasses) supplemented with chondrogenic inducers for 14 days.
Proteins in the conditioned media from the two cell populations were
combined, separated by 1D-SDS-PAGE and subjected to in-gel trypsin
digestion using an automatic digestor. The resulting peptide mixtures
were analyzed by nanoLC coupled on-line to an LTQ-Orbitrap XL mass
spectrometer and quantiﬁed using the MaxQuant software and the
Perseus tool.
Results: Real-Time PCR assays showed a relevant difference in the gene
expression of collagen type II in the normal donors when compared to
the OA patients. Moreover, the chondrocyte phenotype was conﬁrmed
in both cases by the proteglycan immunostainings such as aggrecan and
chondroitin-6-sulfate after 14 days in chondrogenesis. Using the pro-
teomic approach, we compared the extracellular protein proﬁles of OA
and normal hBMSC at the same time of differentiation. Among the 531
proteins, 56 had signiﬁcantly altered levels. 35 proteins displayed
consistently higher levels in the OA samples compared to normal
